Research Projects & Grants

For Profit Organization

  • A Prospective, Multicountry Study to Estimate the Incidence of and Provide a Best Practice Model for Monitoring the Development of Post-Stroke Spasticity, Role: PI, Ipsen Pharma SAS, (04/2025) Status: Approved
  • An Open-Label Study to Evaluate the Phannacokinetics, Phannacodynamics, Efficacy, and Safety of a Single Dose of ANX005 in Participants With Guillain-Barre Syndrome. Protocol: ANX00S-GBS-05, Role: PI, Annexon, Inc., (04/2026 - 04/2027) Status: Approved
  • GORE® CARDIOFORM Septal Occluder and Antiplatelet medical management for reduction of recurrent stroke in patients with Patent Foremen Ovale (PFO): The REDUCE post approval study, Role: Investigator, W.L. Gore & Associates, Inc., (05/2026 - 05/2027) Status: Approved
  • Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION): A Multicenter, Double-Blind, Placebo Controlled, Randomized, Parallel-Group, Phase 2/3 Study to Evaluate the Efficacy and Safety of JXlO in Acute lschemic Stroke with Late Presentations. Protocol: Jx:10002, Role: PI, Corxel Pharmaceuticals, (02/2026 - 02/2027) Status: Approved

Internal

  • Early detection of Dementia using Loma Linda Learning and Memory Assessment (LLAMA), Role: Investigator, LLU Dept. of Neurology, (04/2026) Status: Approved

Non-Profit Organization

  • A RANDOMIZED CONTROLLED, OPEN-LABEL, RATER-BLINDED PRAGMATIC TRIAL, "TREATMENT OF INFLAMMATORY MYELITIS AND OPTIC NEURITIS WITH EARLY VERSUS RESCUE PLASMA EXCHANGE" (TIMELY-PLEX), Role: PD/PI, Mayo Clinic, (07/2026 - 06/2031) Status: Awarded